Arcus biosciences presents data from its pipeline at multiple scientific conferences

Hayward, calif.--(business wire)--arcus biosciences, inc. (nyse:rcus), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced several poster presentations at upcoming scientific conferences that support the ongoing investigation of its clinical and preclinical pipeline. “scientific exchange fosters progress in research, and we value the opportunity to contribute to the advancement of can
RCUS Ratings Summary
RCUS Quant Ranking